SEC Tracker
Get the app

FMC FMC

FMC Q2 FY26: revenue $867.1M, down 17%; diluted EPS −$1.49

Form
10-Q
Filed
Period
Importance
Notable

Key figures from this report

These are the numbers FMC reported for Q2 FY26, the quarter ended Jun 30, 2026, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

  1. Revenue$867.1M−17% from $1.1B in Q2 FY2510-Q income statement, on EDGAR
  2. Net income−$186.6M−380% from $66.7M in Q2 FY2510-Q income statement, on EDGAR
  3. Diluted EPS−$1.49−381% from $0.53 in Q2 FY2510-Q income statement, on EDGAR
  4. Cash and cash equivalents$476.6M+9% from $438.2M in Q2 FY2510-Q balance sheet, on EDGAR

Every quarter in the financial tables

View on EDGAR

Open in the app

Get an email when FMC files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2800 and related industry codes: the same peer list as the financial tables.

  1. Balchem BCPC public float $5.1B, Jun 30, 2025
  2. OLIN OLN public float $2.3B, Jun 30, 2025
  3. Perimeter Solutions PRM public float $1.9B, Jun 30, 2025
  4. Huntsman HUN public float $1.7B, Jun 30, 2025
  5. Chemours CC public float $1.7B, Jun 30, 2025